MLchartDataset catalogue

Duborimycin

Term · Oncology and biomedicine · MLC-T-ONC-013183

An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Duborimycin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.

Table 1. Record
IdentifierMLC-T-ONC-013183
FieldOncology and biomedicine
Synonyms13-Hydroxydaunomycin; Daunomycinol HCl; Daunomycinol; Daunorubicineal; Duborimycin Hydrochloride; Duborimycine, Hydrochloride; Duborimycine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013183",
  "term": "Duborimycin",
  "field": "Oncology and biomedicine",
  "definition": "An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Duborimycin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.",
  "synonyms": [
    "13-Hydroxydaunomycin",
    "Daunomycinol HCl",
    "Daunomycinol",
    "Daunorubicineal",
    "Duborimycin Hydrochloride",
    "Duborimycine, Hydrochloride",
    "Duborimycine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/duborimycin/"
}

Record 6,277 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.